Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea · Delayed Price · Currency is KRW 4,455.00
+15.00 (0.34%)
At close: Oct 2, 2026
Sinsin Pharmaceutical Market Cap
Sinsin Pharmaceutical has a market cap or net worth of 67.58 billion as of October 2, 2026. Its market cap has decreased by -20.02% in one year.
Market Cap
67.58B
Enterprise Value
104.31B
Revenue
123.05B
Ranking
n/a
PE Ratio
5.03
Stock Price
4,455.00
ChartMarket Cap Chart
Since February 28, 2017, Sinsin Pharmaceutical's market cap has decreased from 121.67B to 67.58B, a decrease of -44.45%. That is a compound annual growth rate of -5.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 67.58B | -23.98% |
| Dec 30, 2025 | 88.90B | 7.92% |
| Dec 30, 2024 | 82.38B | -12.98% |
| Dec 28, 2023 | 94.66B | 11.83% |
| Dec 29, 2022 | 84.65B | -13.49% |
| Dec 30, 2021 | 97.85B | -29.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samik Pharmaceutical Company LTD. | 86.08B |
| Sam-A Pharm. | 82.40B |
| KOREA PHARMA | 81.80B |
| Pharos iBio | 79.49B |
| Daehan Nupharm | 77.62B |
| Sinil Pharmaceutical | 73.72B |
| Polaris AI Pharma | 72.66B |
| GL Pharm Tech | 66.07B |